DAIC

FEBRUARY 6, 2024

EGF mapping allows physicians to detect EGF sources and is designed to individualize ablation strategies based on underlying pathophysiologic mechanisms to potentially improve outcomes. By guiding ablation therapy, [EGF mapping] can enable clinicians to provide personalized, highly targeted treatment."

Ablation 104

Ablation Atrial Fibrillation AFIB Pulmonary 104

DAIC

JANUARY 31, 2024

Food and Drug Administration (FDA), has granted approval to Boston Scientific for its FARAPULSE Pulsed Field Ablation System. intermittent) atrial fibrillation (AF) and is a unique new alternative to standard-of-care thermal ablation treatment. said Nick Spadea-Anello, president, Electrophysiology, Boston Scientific. "The

Ablation 111

Ablation Atrial Fibrillation Anatomy Pulmonary 111

DAIC

FEBRUARY 2, 2024

milla1cf Fri, 02/02/2024 - 17:18 February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 with CardioLab EP Recording system, to help clinicians in the diagnosis and treatment of cardiac arrhythmias. million people in the United States by 2050 and 17.9 million in Europe by 2060.

Electrophysiology 101

Electrophysiology Innovation AFIB Atrial Fibrillation 101

Journal of Cardiovascular Electrophysiology

JANUARY 28, 2024

Abstract Introduction Some previous studies have reported that a first-step ethanol infusion into the vein of Marshall (EIVOM) with touch-up radiofrequency (RF) ablation can facilitate mitral isthmus (MI) block and improves the ablation outcomes in persistent atrial fibrillation (PeAF) patients. 0.78, p  = .006).

Atrial Fibrillation 75

Atrial Fibrillation Ablation Bicuspid/Mitral Tachycardia 75

Heart BMJ

JANUARY 10, 2024

Objective Catheter ablation of atrial fibrillation effectively reduces symptomatic burden. We investigated if patients with atrial fibrillation who undergo catheter ablation have lower risk for all-cause mortality or stroke than patients who are managed medically. ±1.5, vs 28.9%, p<0.001).

Atrial Fibrillation 52

Atrial Fibrillation Ablation Stroke Strokes 52

American College of Cardiology

MARCH 8, 2024

PT is an 82-year-old man who presents with persistent, mildly symptomatic atrial fibrillation (AF) of approximately 4-5 months' duration.

Atrial Fibrillation 56

Atrial Fibrillation Electrophysiology Ablation Article 56

Dr. Smith's ECG Blog

MAY 7, 2024

Definitely atrial fibrillation. Probably WPW but is very slow for atrial fib withWPW. So this looks like WPW with Atrial fibrillation. What is unusual is that the rate is not REALLY fast, as you expect when there is atrial fib with an accessory pathway. My response: "Definitely not polymorphic VT.

Atrial Fibrillation 124

Atrial Fibrillation AFIB Ablation Chest Pain 124

ADN Center of Excellence

MAY 17, 2024

It is with great pride that we announce the resounding success of ADN CoE' s AFib Ablation Training program, the second installment in our esteemed Ablation Series, held at the prestigious 9 Eylül University Heart Rhythm Management Centre.

Atrial Fibrillation 59

Atrial Fibrillation AFIB Ablation Heart Rhythm 59

DAIC

JANUARY 18, 2024

milla1cf Thu, 01/18/2024 - 14:21 January 18, 2024 — Abbott announced the first global procedures have been conducted using the company's new Volt Pulsed Field Ablation (PFA) System to treat patients battling common abnormal heart rhythms such as atrial fibrillation (AFib).

Heart Rhythm 105

Heart Rhythm Ablation AFIB Chest Pain 105

ADN Center of Excellence

MAY 17, 2024

It is with great pride that we announce the resounding success of ADN CoE' s AFib Ablation Training program, the second installment in our esteemed Ablation Series, held at the prestigious 9 Eylül University Heart Rhythm Management Centre.

Atrial Fibrillation 52

Atrial Fibrillation AFIB Ablation Heart Rhythm 52

Frontiers in Cardiovascular Medicine

FEBRUARY 11, 2024

Despite the relative efficacy of ablation, the risk of AF recurrence is substantial, particularly in patients with persistent AF (perAF). At present we do not have any reliable intra-procedural electrophysiologic predictors of long-term success of AF ablation other than pulmonary vein isolation.

Pulmonary 64

Pulmonary Ablation Atrial Fibrillation Electrophysiology 64

HeartRhythm

AUGUST 27, 2024

Epicardial Marshall bundle (MB) are frequently utilized in left atrial tachycardias (LATs) post atrial fibrillation (AF) ablation with pulmonary vein isolation and substrate modification.

Atrial Fibrillation 40

Atrial Fibrillation Tachycardia Ablation Electrophysiology 40

American College of Cardiology

APRIL 24, 2024

The PRO portion of the currently featured PRO/CON debate between Dr. Brian Olshansky and Dr. John Mandrola presents a significant conundrum within the fields of electrophysiology and geriatric cardiology.

Atrial Fibrillation 63

Atrial Fibrillation Heart Failure Electrophysiology Ablation 63

DAIC

JUNE 11, 2024

In electrophysiology, innovation is king, but it is often incremental, and it almost always lacks rationale, comprehensive clinical documentation and relevance for hospitals that try to balance the increasing costs of new technology with increasing demand and reimbursement that just can’t keep pace.

Innovation 104

Innovation AFIB Technology Electrophysiology 104

HeartRhythm

APRIL 30, 2024

Surgical Cox-Maze strategy yields favorable outcomes for patients with persistent atrial fibrillation (PeAF).

Atrial Fibrillation 40

Atrial Fibrillation Electrophysiology Ablation Outcomes 40

All About Cardiovascular System and Disorders

OCTOBER 25, 2023

Rate vs Rhythm Control in Atrial Fibrillation Rate vs rhythm control as a management strategy in atrial fibrillation has been a long standing topic for debate. Nearly two thirds in the rhythm control strategy were on amiodarone and only 14 had catheter ablation. Many were not in sinus rhythm or anticoagulated.

Atrial Fibrillation 52

Atrial Fibrillation Heart Failure Ablation Cardiac Arrest 52

Journal of Cardiovascular Electrophysiology

JANUARY 15, 2024

Abstract Introduction Atrial fibrillation and atrial flutter originating from the donor s heart is a commonly reported complication post heart transplant. Case A 47-year-old male presented with atrial tachycardia 6 months post heart transplant. This arrhythmia was successfully terminated with radiofrequency ablation.

Atrial Fibrillation 40

Atrial Fibrillation Heart Transplant Atrial Flutter Transplant 40

Circulation: Arrhythmia and Electrophysiology

DECEMBER 21, 2023

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Inflammation may promote atrial fibrillation (AF) recurrence after catheter ablation. The first dose of the study drug was administered within 4 hours before ablation. mg twice daily or placebo for 10 days. 2.02];P=0.89). 1.99];P=0.55).CONCLUSIONS:Colchicine

Atrial Fibrillation 40

Atrial Fibrillation Ablation Chest Pain Atrial Flutter 40

CardiacWire

DECEMBER 17, 2023

The AFib pulsed field ablation treatment era officially began in the US last week, following the FDA approval of Medtronic’s PulseSelect Pulsed Field Ablation System for the treatment of both paroxysmal and persistent atrial fibrillation.

AFIB 105

AFIB Ablation Atrial Fibrillation Pulmonary 105

American College of Cardiology

APRIL 24, 2024

PT is an 82-year-old man who presents with persistent, mildly symptomatic atrial fibrillation (AF) of approximately 4-5 months' duration. He also has New York Heart Association (NYHA) class II heart failure with reduced ejection fraction and left ventricular ejection fraction (LVEF) 40%.

Atrial Fibrillation 40

Atrial Fibrillation Electrophysiology Heart Failure Ablation 40

Dr. Smith's ECG Blog

JUNE 11, 2023

The differential of wide complex irregularly irregular includes: polymorphic VT, atrial fibrillation with WPW, atrial fibrillation with other aberrancy. Thus, the patients rhythm is atrial fibrillation with WPW. An accessory pathway was identified and was ablated.

Tachycardia 91

Tachycardia Atrial Fibrillation Chest Pain Blood Pressure 91

Circulation: Arrhythmia and Electrophysiology

JANUARY 29, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:High-power short-duration ablation has shown impressive efficacy and safety for pulmonary vein isolation (PVI); however, initial efficacy results with very high power short-duration ablation were discouraging. or acute reconnection (4% versus 14%;P=0.3)

Electrophysiology 76

Electrophysiology Atrial Fibrillation Pulmonary Ablation 76

HeartRhythm

APRIL 30, 2024

While the application of artificial intelligence (AI) in cardiovascular medicine is rising especially for wearable, smart and implantable devices, its use in interventional electrophysiology during an atrial fibrillation (AF) catheter ablation procedure is still emerging.

Atrial Fibrillation 40

Atrial Fibrillation Electrophysiology Ablation 40

DAIC

OCTOBER 21, 2024

FDA approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of paroxysmal atrial fibrillation and FDA 510(k) clearance for the new FARAVIEW Software, which will combine to provide visualization for cardiac ablation procedures with the FARAPULSE Pulsed Field Ablation System.

Ablation 52

Ablation Atrial Fibrillation Technology Electrophysiology 52

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

Abstract Introduction Earlier studies have shown a clear association between severity of human immunodeficiency virus (HIV) infection and incident atrial fibrillation (AF). We present the long-term outcome of catheter ablation (CA) and electrophysiological characteristics in HIV+ AF patients. vs. 54%, p  < .001],

Atrial Fibrillation 40

Atrial Fibrillation Ablation Outcomes Arrhythmia 40

Journal of Cardiovascular Electrophysiology

OCTOBER 30, 2024

Abstract Introduction The impact of repeated atrial fibrillation (AF) ablations on left atrial (LA) mechanical function remains uncertain, with limited long-term follow-up data. In the sub-study 2 with four MRIs, all three rates were negative, with reductions from postablation 1 to pre-ablation 2 ( r 22  =  − 13.3 ± 2.6%/year,

Atrial Fibrillation 40

Atrial Fibrillation Ablation Article 40

HeartRhythm

APRIL 30, 2024

Atypical Atrial Flutter (AAFL) prevalence is increasing due to the escalating Atrial Fibrillation (AF) ablations and cardiac surgeries. We wanted to explore the outcome of the AAFL ablation, considering the recent changes in mapping and ablation.

Atrial Flutter 40

Atrial Flutter Ablation Electrophysiology Atrial Fibrillation 40

Journal of Cardiovascular Electrophysiology

JANUARY 28, 2024

Abstract Objective To evaluate the progression of electrophysiological phenomena in atrial fibrillation (AF) and elucidate the association between the left atrial conduction velocity (LACV) and AF recurrence after pulmonary vein isolation.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Pulmonary Bicuspid/Mitral 40

American College of Cardiology

APRIL 24, 2024

Brian Olshansky and John Mandrola currently featured presents a conundrum within the fields of electrophysiology and geriatric cardiology. The CON portion of the PRO/CON debate between Drs.

Atrial Fibrillation 53

Atrial Fibrillation Electrophysiology Heart Failure Ablation 53

Journal of Cardiovascular Electrophysiology

AUGUST 7, 2023

Abstract A vast amount of now well-established clinical and epidemiological data indicates a close, interdependent, and symbiotic association between atrial fibrillation (AF) and heart failure (HF). whether ablation is mandatory or pointless in patients who have HF).

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation Outcomes 40

DAIC

DECEMBER 26, 2023

a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, announced the completion of the first five procedures in its first-in-human feasibility study with its novel CellFX nsPFA cardiac catheter.

Ablation 59

Ablation Atrial Fibrillation Technology Hospital 59

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

The study investigated the outcomes of 400 patients with PAF who underwent an index ablation procedure, while also identifying the predictors associated with recurrence and progression to PersAF. CI, confidence interval; OR, odd ratio; PAF, paroxysmal atrial fibrillation; PersAF, persistent atrial fibrillation; SR, sinus rhythm.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Pulmonary Outcomes 40

Dr. Smith's ECG Blog

JANUARY 9, 2024

She also has a hx of paroxysmal atrial fibrillation and is on oral anticoagulant treatment. After atrial rhythm/SR was restored the patient slowly improved. Medical treatment for heart failure was optimized and after a few days the patient was discharged with referral to VT ablation procedure.

Tachycardia 106

Tachycardia Electrophysiology Atrial Flutter Ischemia 106

Frontiers in Cardiovascular Medicine

JANUARY 10, 2024

However, widely split P' waves in focal atrial tachycardia (AT) on a surface electrocardiogram (ECG) have rarely been reported. The electrophysiological mechanism is relatively difficult to clarify, requiring a electrophysiological study. P' waves were markedly prolonged in duration and widely split in morphology.

Tachycardia 59

Tachycardia Electrophysiology Atrial Fibrillation Electrocardiogram 59

Journal of Cardiovascular Electrophysiology

JANUARY 28, 2024

Abstract Introduction The optimized ablation index (AI) value for catheter ablation of atrial fibrillation (AF) remains to be defined. Methods and Results Patients with symptomatic, drug-resistant paroxysmal AF for first ablation were prospectively enrolled from September 2020 to January 2022.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Arrhythmia Pulmonary 40

Journal of Cardiovascular Electrophysiology

JANUARY 10, 2024

Abstract Introduction Despite advanced ablation strategies and major technological improvements, treatment of persistent atrial fibrillation (AF) remains challenging and the underlying pathophysiology is not fully understood. ms after) and AF termination to atrial tachycardia (AT) or sinus rhythm (SR) in 12 patients (24%).

Atrial Fibrillation 40

Atrial Fibrillation Ablation Outpatient Arrhythmia 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 5, 2023

Abstract Introduction Influence of early atrial fibrillation (AF) ablation, particularly cryoballoon ablation (CBA), on clinical outcome during long-term follow-up has not been clarified. Methods The study included 2605 patients from Korean CBA registry data with follow-up >12 months after de novo CBA.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Outcomes Kidney Disease 40